AU2001255448A1 - Alpha-2 adrenergic receptor polymorphisms - Google Patents

Alpha-2 adrenergic receptor polymorphisms

Info

Publication number
AU2001255448A1
AU2001255448A1 AU2001255448A AU5544801A AU2001255448A1 AU 2001255448 A1 AU2001255448 A1 AU 2001255448A1 AU 2001255448 A AU2001255448 A AU 2001255448A AU 5544801 A AU5544801 A AU 5544801A AU 2001255448 A1 AU2001255448 A1 AU 2001255448A1
Authority
AU
Australia
Prior art keywords
alpha
adrenergic receptor
receptor polymorphisms
polymorphisms
adrenergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255448A
Inventor
Stephen B. Liggett
Kirsten M. Small
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KIRSTEN M SMALL
STEPHEN B LIGGETT
Original Assignee
KIRSTEN M SMALL
STEPHEN B LIGGETT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/692,077 external-priority patent/US7229756B1/en
Application filed by KIRSTEN M SMALL, STEPHEN B LIGGETT filed Critical KIRSTEN M SMALL
Publication of AU2001255448A1 publication Critical patent/AU2001255448A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001255448A 2000-04-17 2001-04-17 Alpha-2 adrenergic receptor polymorphisms Abandoned AU2001255448A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US55174400A 2000-04-17 2000-04-17
US09/551,744 2000-04-17
US63625900A 2000-08-10 2000-08-10
US09/636,259 2000-08-10
US09/692,077 2000-10-19
US09/692,077 US7229756B1 (en) 2000-10-19 2000-10-19 Alpha-2B-adrenergic receptor polymorphisms
PCT/US2001/012575 WO2001079561A2 (en) 2000-04-17 2001-04-17 Alpha-2 adrenergic receptor polymorphisms

Publications (1)

Publication Number Publication Date
AU2001255448A1 true AU2001255448A1 (en) 2001-10-30

Family

ID=27415627

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255448A Abandoned AU2001255448A1 (en) 2000-04-17 2001-04-17 Alpha-2 adrenergic receptor polymorphisms

Country Status (3)

Country Link
US (2) US7041810B2 (en)
AU (1) AU2001255448A1 (en)
WO (1) WO2001079561A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642052B2 (en) 2002-09-09 2010-01-05 University Of Cincinnati Heart failure assessment based on alpha-2C adrenergic receptor polymorphisms
CA2538222A1 (en) 2003-09-12 2005-03-24 Stephen Bryant Liggett Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms
WO2005071105A1 (en) * 2004-01-07 2005-08-04 Fu Wai Hospital Chinese Academy Of Medical Sciences An essential hypertension associated gene and the detecting method and the usage thereof
EP1802775B1 (en) 2004-09-14 2010-05-26 The Regents of the University of Colorado Method for treatment with bucindolol based on genetic targeting
WO2006076655A2 (en) * 2005-01-13 2006-07-20 Perlegen Sciences, Inc. Use of alpha-2 adrenergic receptor agonists
EP1892302A1 (en) * 2005-06-16 2008-02-27 BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. Nucleic acid detection method involving the direct generation of a measurable signal
US20090220507A1 (en) * 2005-07-22 2009-09-03 Sucharov Carmen C Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure
EP1907589A4 (en) * 2005-07-26 2010-11-24 Siemens Healthcare Diagnostics Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
EP2041304B1 (en) * 2006-06-12 2011-09-07 Hadasit Medical Research Services & Development Limited Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication
CN104017071B (en) 2006-06-13 2017-08-15 赫里克斯生物医疗公司 The fragments of peptides synthesized for inducing cell extracellular matrix protein
US20080228698A1 (en) 2007-03-16 2008-09-18 Expanse Networks, Inc. Creation of Attribute Combination Databases
EE200700019A (en) * 2007-04-27 2008-12-15 Tartu Ülikool Method and kit for identifying a person who has a genetic predisposition to overeating
US20090043752A1 (en) 2007-08-08 2009-02-12 Expanse Networks, Inc. Predicting Side Effect Attributes
US8200509B2 (en) 2008-09-10 2012-06-12 Expanse Networks, Inc. Masked data record access
US7917438B2 (en) * 2008-09-10 2011-03-29 Expanse Networks, Inc. System for secure mobile healthcare selection
US8108406B2 (en) 2008-12-30 2012-01-31 Expanse Networks, Inc. Pangenetic web user behavior prediction system
US8255403B2 (en) 2008-12-30 2012-08-28 Expanse Networks, Inc. Pangenetic web satisfaction prediction system
US8386519B2 (en) 2008-12-30 2013-02-26 Expanse Networks, Inc. Pangenetic web item recommendation system
WO2010077336A1 (en) 2008-12-31 2010-07-08 23Andme, Inc. Finding relatives in a database
WO2012104851A1 (en) * 2011-01-31 2012-08-09 Yeda Research And Development Co. Ltd. Methods of diagnosing disease using overlap extension pcr
EP2821072A1 (en) * 2013-07-01 2015-01-07 Ecole Polytechnique Fédérale de Lausanne (EPFL) Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord disorders
DE18205817T1 (en) 2018-11-13 2020-12-24 Gtx Medical B.V. SENSOR IN CLOTHING OF LIMBS OR FOOTWEAR

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856092A (en) * 1989-02-13 1999-01-05 Geneco Pty Ltd Detection of a nucleic acid sequence or a change therein
US5053337A (en) * 1989-10-30 1991-10-01 Neurogenetic Corporation DNA encoding an α2B -adrenergic receptor
GB9001181D0 (en) * 1990-01-18 1990-03-21 Imp Cancer Res Tech Genetic assay
US6013431A (en) * 1990-02-16 2000-01-11 Molecular Tool, Inc. Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators
DE69126064T2 (en) * 1990-06-22 1997-08-28 Hoffmann La Roche Detection of weak metabolizing agents of drugs
US5846710A (en) * 1990-11-02 1998-12-08 St. Louis University Method for the detection of genetic diseases and gene sequence variations by single nucleotide primer extension
US6004744A (en) * 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
US5888819A (en) * 1991-03-05 1999-03-30 Molecular Tool, Inc. Method for determining nucleotide identity through primer extension
JPH06121686A (en) 1992-10-12 1994-05-06 Asahi Chem Ind Co Ltd Gene capable of coding adrenaline receptor
JPH10501122A (en) 1994-05-27 1998-02-03 グラクソ、グループ、リミテッド P ▲ 2X ▼ receptor (purinoceptor family)
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
JPH114695A (en) * 1997-04-25 1999-01-12 Hayashibara Biochem Lab Inc Hedgehog protein
US6498009B1 (en) 1997-10-10 2002-12-24 University Of Cincinnati β-adrenergic receptor polymorphisms
US6166503A (en) * 1997-11-26 2000-12-26 Seagate Technology Llc Disc drive spindle motor with programmable current control
US6821724B1 (en) * 1998-09-17 2004-11-23 Affymetrix, Inc. Methods of genetic analysis using nucleic acid arrays
JP2002526100A (en) 1998-10-07 2002-08-20 ワーナー−ランバート・カンパニー Alpha-2 / delta gene
GB2361535B (en) 1998-11-25 2004-02-25 Univ Cincinnati Polymorphisms in the 5'leader cistron of the beta 2 - adrenergic receptor
EP1222204A1 (en) * 1999-10-22 2002-07-17 Oy Juvantia Pharma Ltd A DNA MOLECULE ENCODING A VARIANT $g(a) 2B?-ADRENOCEPTOR PROTEIN, AND USES THEREOF

Also Published As

Publication number Publication date
US7572603B2 (en) 2009-08-11
US20030113725A1 (en) 2003-06-19
WO2001079561A9 (en) 2002-12-19
US20060073508A1 (en) 2006-04-06
US7041810B2 (en) 2006-05-09
WO2001079561A2 (en) 2001-10-25
WO2001079561A3 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
AU2001255448A1 (en) Alpha-2 adrenergic receptor polymorphisms
GB2371418B (en) Structure for waterproofing terminal-wire connecting portion
AU4802500A (en) 2-aminoquinolinecarboxamides: neurokinin receptor ligands
AU2001250205A1 (en) Prostaglandin d2 receptor antagonists
AU2001259561A1 (en) Tgfbeta-rii promoter polymorphisms
AU2001245724A1 (en) Il-8 receptor antagonists
AU2001240021A1 (en) Diazafluorenone il-8 receptor antagonists
AU1073501A (en) Histamine receptor
AU2002216079A1 (en) Bombesin receptor antagonists
AU2001243351A1 (en) Il-8 receptor antagonists
AU5786300A (en) Muscarinic antagonists
AU2002217095A1 (en) Bombesin receptor antagonists
AU2001237546A1 (en) Methods for characterizing polymorphisms
AU2001241896A1 (en) Il-8 receptor antagonists
AU2001253172A1 (en) Il-8 receptor antagonists
AU2258601A (en) Ibd-related polymorphisms
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
AU5022200A (en) Tm4sf receptors
AU2001223882A1 (en) Receptor
AUPQ563400A0 (en) Novel receptor
AU2001245605A1 (en) Il-8 receptor antagonists
AU2001277507A1 (en) Mailer - postal service interfaces
AU1155801A (en) Adaptor receptors
AU2002351434A1 (en) Facsimile machine
AU1387801A (en) Construction machine